LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture

@article{Shields2018LARGEUM,
  title={LARGE UVEAL MELANOMA (≥10 MM THICKNESS): Clinical Features and Millimeter-by-Millimeter Risk of Metastasis in 1311 Cases. The 2018 Albert E. Finley Lecture},
  author={C. Shields and Kareem Sioufi and Justin S. Robbins and Laura E Barna and Maxwell R Harley and S. Lally and E. Say and A. Mashayekhi and J. Shields},
  journal={Retina},
  year={2018},
  volume={38},
  pages={2010–2022}
}
Purpose: To analyze the clinical features and rate of metastatic disease in eyes with large (≥10 mm thickness) uveal melanoma. Design: Retrospective noncomparative case series. Participants: There were 1,311 consecutive patients. Methods: Retrospective medical chart review. Main outcome measures: Clinical features and rate of metastatic melanoma. Results: Of 1,311 patients with large melanoma, the mean age was 59 years (median 60, range 6–98 years) and 95% were white. Mean tumor basal dimension… Expand
11 Citations
Primary Sites of Uveal Melanoma Associated with Distinct Survival Outcomes and Clinicopathological Features: A SEER Population-Based Study of 4359 Cases
  • Xin Liang, Yan Rong, Junming Wang, Hong Zhang
  • Medicine
  • International journal of general medicine
  • 2021
Objective We sought to investigate clinicopathological characteristics correlated with the prognosis of uveal melanoma (UM) patients and find the driving factors of prognosis for ciliary/irisExpand
Distant metastasis in choroidal melanoma with spontaneous corneal perforation and intratumoral calcification: A case report
TLDR
A 63-year-old Asian woman with unique presentations of choroidal melanoma is presented with a large mass at the upper abdomen abutting the pancreatic neck and body as well as several nodular lesions in the liver. Expand
Uveal melanoma in 2020: Does size still matter?
TLDR
The Collaborative Ocular Melanoma Study confirmed brachytherapy to be equivalent to enucleation with regard to survival, melanoma-related mortality to be unrelated to treatment and that growth might occur in up to 31% of untreated small melanomas at 5 years. Expand
Uveal melanoma
TLDR
This Primer describes the clinical and biological features of primary UM, and highlights how therapies to prevent and treat the (currently) deadly metastases are urgently needed. Expand
Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors
TLDR
The data suggest that loss of nATM protein might serve as a poor prognostic marker in the pathogenesis of uveal melanoma which may lead to increased risk of metastasis. Expand
Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma.
TLDR
The data suggest that loss of BAP1 along with ATM might serve as a potential prognostic indicator in patients with an advanced AJCC tumor category, which leads to an increased risk of metastasis. Expand
Heterogeneity of GNAQ/11 mutation inversely correlates with the metastatic rate in uveal melanoma
TLDR
The tumour with heterogeneous mutation of GNAQ/11 is more likely to develop a poor prognosis than that with homogeneous mutationOf GNAZ/11 and the mutation ratio of G NAQ/ 11 in UM was quite variable. Expand
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma
TLDR
The meta-analysis showed no difference in tumor control, survival and toxicities, as defined in this paper, between SRS and fSRT for uveal melanoma. Expand
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
TLDR
Recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup are described. Expand
Impact of uveal melanoma thickness on post‐plaque radiotherapy outcomes in the prophylactic anti‐vascular endothelial growth factor era in 1131 patients
The impact of tumour thickness on radiation complications following plaque radiotherapy for uveal melanoma in the anti‐vascular endothelial growth factor (VEGF) era remains unknown.
...
1
2
...

References

SHOWING 1-10 OF 40 REFERENCES
Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
TLDR
Plaque radiotherapy provided tumor control at 10 years in 87% of patients with selected large posterior uveal melanomas (>8 mm thick) that otherwise would have been managed with enucleation that otherwise wouldn't have beenmanaged using Cox proportional hazards regression models. Expand
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
TLDR
Increasing millimeter thickness of uveal melanoma is associated with increasing risk for metastasis, and clinical factors predictive of metastasis by multivariate analysis included increasing patient age, ciliary body location, increase tumor diameter, increasing tumor thickness, having a brown tumor, and the presence of subretinal fluid, intraocular hemorrhage, or extraocular extension. Expand
Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
TLDR
The results suggest that management of small melanoma might reduce chromosomal instability and improve overall patient survival, and increasing melanoma size demonstrates greater cytogenetic alterations. Expand
American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.
TLDR
The clinical features and prognosis of posterior uveal melanoma based on the American Joint Committee on Cancer (AJCC) (7th edition) tumor staging were analyzed, finding that the rate of metastasis/death was 3 times greater for stage II, 9 to 10 times greatest for stage III, and further great for stage IV. Expand
CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES
TLDR
Compared with mid adults and older adults, young and mid adults showed smaller melanoma basal dimension and lower tumor-related metastasis and death and concluded that young patients manifested a higher proportion of iris melanoma. Expand
American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
TLDR
Based on the AJCC classification, increasing tumor category was associated with older age, larger tumor, and greater incidence of subretinal fluid, hemorrhage, and extraocular extension. Expand
Comparison of Clinical Outcomes for Patients with Large Choroidal Melanoma after Primary Treatment with Enucleation or Proton Beam Radiotherapy
TLDR
Although enucleation is the most common primary treatment for large uveal melanomas, PBRT is an eye-preserving option that may be considered for some patients. Expand
Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture
TLDR
Uveal melanoma showed similar prognosis for all races, and despite relative risk for metastasis of 0.31 for African Americans, 0.73 for Hispanics, and 1.42 for Asians, there was no statistical difference in metastasis, or death from uveAL melanoma based on race. Expand
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
  • B. Hawkins
  • Medicine
  • American journal of ophthalmology
  • 2004
TLDR
Longer follow-up confirmed the earlier report of no survival advantage attributable to pre-enucleation radiation and Mortality rates by baseline characteristics should facilitate counseling of patients who have large choroidal melanoma and no evidence of metastasis or another malignancy at diagnosis. Expand
Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.
TLDR
Patients with large melanomas eligible for TTR retain a better visual function and have a lower incidence of secondary glaucoma than those treated by (125)I brachytherapy. Expand
...
1
2
3
4
...